Shareholding disclosure

NWB INVESTISSEMENTS SPRL

Declared position

Threshold

Fell below threshold

Timeline

Published

29.03.2012

Transaction

23.03.2012

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAC3S00048

Beneficial owner

NWB INVESTISSEMENTS SPRL

Declared address

NWB INVESTISSEMENTS SPRL, 1050 Ixelles

Sell off order book of all their shares

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

NWB INVESTISSEMENTS SPRL

Newron Pharmaceuticals S.p.A.29.03.2012TAC3S00048

Disclosure summary

NWB INVESTISSEMENTS SPRL disclosed a holding in Newron Pharmaceuticals S.p.A. that fell below the publication threshold, published by SIX Exchange Regulation on 29.03.2012, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

NWB INVESTISSEMENTS SPRL disclosed a holding in Newron Pharmaceuticals S.p.A., published on 29.03.2012.

Publication date29.03.2012

Transaction date23.03.2012

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerNWB INVESTISSEMENTS SPRL

Declared addressNWB INVESTISSEMENTS SPRL, 1050 Ixelles

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAC3S00048

Conditions

Sell off order book of all their shares

Source: SIX Exchange Regulation · Publication date: 29.03.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open